Radiopharmaceuticals

LOS ANGELES, California, June 1, 2026 ITM Isotope Technologies Munich SE announced new findings from its Phase 3 COMPETE...

NEW YORK, May 29, 2026 Actinium Pharmaceuticals, Inc. has announced the receipt of two patent allowances from the Canadian...

BOSTON, May 29, 2026 Ratio Therapeutics has expanded its manufacturing collaboration with PharmaLogic Holdings Corp. to support the clinical...

STOCKHOLM, Sweden – May 6, 2026 Spago Nanomedical AB (publ) has announced that its ongoing Phase I/IIa Tumorad-01 study...

ALBUQUERQUE, N.M., May 5, 2026 Eden Radioisotopes, LLC has filed a Construction Permit Application with the U.S. Nuclear Regulatory...

Melbourne, Australia and Indianapolis, IN, United States – May 5, 2026 Telix Pharmaceuticals Limited has announced the publication of...

BOSTON, May 04, 2026 Aktis Oncology has announced the initiation of a Phase 1b clinical trial evaluating AKY-2519, a...

ATLANTA, Georgia, USA, April 28, 2026 PharmaLogic Holdings Corp., a leading contract development and manufacturing organization (CDMO) specializing in...

Florham Park, N.J., April 21, 2026 Cellectar Biosciences, Inc. announced that a subset analysis from its CLOVER WaM clinical...

SYDNEY, April 16, 2026 Radiopharmaceutical innovation continues to reshape oncology diagnostics as Radiopharm Theranostics announced completion of enrollment in...